«
»

BioNTech’s mRNA Cancer Vaccine Has Started Phase 2 Clinical Trial

Added on December 23rd, 2021 by | Report Post
Tags:,

Colorectal cancer was chosen by BioNTech as an experimental vaccine target due to the disease’s relatively high relapse rate.

Via


    • Leave A Comment

    Subscribe
    Notify of
    0 Comments
    Inline Feedbacks
    View all comments

    • here's some related content from the store: